These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 321179)
1. The role of the false neurotransmitter octopamine in the hypotension of fulminant hepatic failure. Trewby PN; Chase RA; Davis M; Williams R Clin Sci Mol Med; 1977 Mar; 52(3):305-10. PubMed ID: 321179 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of hypotension in patients with fulminant hepatic failure. Trewby PN; Williams R Gut; 1977 Dec; 18(12):1021-6. PubMed ID: 606628 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of hepatic encephalopathy and hyperdynamic syndrome in cirrhosis. Role of false neurotransmitters. Nespoli A; Bevilacqua G; Staudacher C; Rossi N; Salerno F; Castelli MR Arch Surg; 1981 Sep; 116(9):1129-38. PubMed ID: 6793024 [TBL] [Abstract][Full Text] [Related]
4. Octopamine and ammonia plasma levels in hepatic encephalopathy. Capocaccia L; Cangiano C; Attili AF; Angelico M; Cascino A; Rossi Fanelli F Clin Chim Acta; 1977 Feb; 75(1):99-105. PubMed ID: 321153 [TBL] [Abstract][Full Text] [Related]
5. Defective cardiovascular reflexes and supersensitivity to sympathomimetic drugs in autonomic failure. Bannister R; Davies B; Holly E; Rosenthal T; Sever P Brain; 1979 Mar; 102(1):163-76. PubMed ID: 427528 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological effects of alpha-methyldopa, alpha-methylnorepinephrine, and octopamine on rat arteriolar, arterial, and terminal vascular smooth. Altura BM Circ Res; 1975 Jun; 36(6 Suppl 1):233-40. PubMed ID: 1093755 [TBL] [Abstract][Full Text] [Related]
13. Octopamine plasma levels and hepatic encephalopathy: a re-appraisal of the problem. Rossi-Fanelli F; Cangiano C; Attili A; Angelico M; Cascino A; Capocaccia L; Strom R; Crifó C Clin Chim Acta; 1976 Mar; 67(3):255-61. PubMed ID: 770031 [TBL] [Abstract][Full Text] [Related]
14. Idiopathic orthostatic hypotension from failure of noradrenaline release in a patient with vasomotor innervation. Nanda RN; Boyle FC; Gillespie JS; Johnson RH; Keogh HJ J Neurol Neurosurg Psychiatry; 1977 Jan; 40(1):11-9. PubMed ID: 191566 [TBL] [Abstract][Full Text] [Related]
15. Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy. Cuilleret G; Pomier-Layrargues G; Pons F; Cadilhac J; Michel H Gut; 1980 Jul; 21(7):565-9. PubMed ID: 6776015 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action. Lenke D; Gries J; Kretzschmar R Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970 [TBL] [Abstract][Full Text] [Related]
17. Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats. Berg T; Piercey BW; Jensen J Hypertension; 2010 May; 55(5):1224-30. PubMed ID: 20231523 [TBL] [Abstract][Full Text] [Related]
18. Pre- and postsynaptic effects of p-tyramine and p-octopamine in the prostatic portion of the rat vas deferens. Celuch SM; Juorio AV Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):39-46. PubMed ID: 2907098 [TBL] [Abstract][Full Text] [Related]
19. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Sørensen SS; Danielsen H; Jespersen B; Pedersen EB Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595 [TBL] [Abstract][Full Text] [Related]
20. Ancient coexistence of norepinephrine, tyramine, and octopamine signaling in bilaterians. Bauknecht P; Jékely G BMC Biol; 2017 Jan; 15(1):6. PubMed ID: 28137258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]